Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 619

1.

Cost-effectiveness of implanted defibrillators in young people with inherited cardiac arrhythmias.

Goldenberg I, Moss AJ, Maron BJ, Dick AW, Zareba W.

Ann Noninvasive Electrocardiol. 2005 Oct;10(4 Suppl):67-83.

PMID:
16274418
2.

Cost-effectiveness of implantable cardioverter defibrillators relative to amiodarone for prevention of sudden cardiac death.

Owens DK, Sanders GD, Harris RA, McDonald KM, Heidenreich PA, Dembitzer AD, Hlatky MA.

Ann Intern Med. 1997 Jan 1;126(1):1-12.

PMID:
8992917
3.

Cost-effectiveness of the implantable cardioverter defibrillator: a review of current evidence.

Lynd LD, O'Brien BJ.

J Cardiovasc Electrophysiol. 2003 Sep;14(9 Suppl):S99-103. Review.

PMID:
12950529
4.

The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator.

Yao G, Freemantle N, Calvert MJ, Bryan S, Daubert JC, Cleland JG.

Eur Heart J. 2007 Jan;28(1):42-51. Epub 2006 Nov 16.

PMID:
17110403
5.

The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.

Fox M, Mealing S, Anderson R, Dean J, Stein K, Price A, Taylor RS.

Health Technol Assess. 2007 Nov;11(47):iii-iv, ix-248. Review.

6.

Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator.

Owens DK, Sanders GD, Heidenreich PA, McDonald KM, Hlatky MA.

Am Heart J. 2002 Sep;144(3):440-8.

PMID:
12228780
8.

Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).

Mark DB, Nelson CL, Anstrom KJ, Al-Khatib SM, Tsiatis AA, Cowper PA, Clapp-Channing NE, Davidson-Ray L, Poole JE, Johnson G, Anderson J, Lee KL, Bardy GH; SCD-HeFT Investigators.

Circulation. 2006 Jul 11;114(2):135-42. Epub 2006 Jul 3.

9.

Cost-effectiveness of implantable cardioverter defibrillators in patients >or=65 years of age.

Sanders GD, Kong MH, Al-Khatib SM, Peterson ED.

Am Heart J. 2010 Jul;160(1):122-31. doi: 10.1016/j.ahj.2010.04.021.

PMID:
20598982
10.

Cost-effectiveness of implantable cardioverter-defibrillators.

Sanders GD, Hlatky MA, Owens DK.

N Engl J Med. 2005 Oct 6;353(14):1471-80.

11.

Cost-effectiveness of implantable defibrillator as first-choice therapy versus electrophysiologically guided, tiered strategy in postinfarct sudden death survivors. A randomized study.

Wever EF, Hauer RN, Schrijvers G, van Capelle FJ, Tijssen JG, Crijns HJ, Algra A, Ramanna H, Bakker PF, Robles de Medina EO.

Circulation. 1996 Feb 1;93(3):489-96.

12.

Cost effectiveness of implantable cardioverter-defibrillators for primary prevention in a Belgian context.

Neyt M, Thiry N, Ramaekers D, Van Brabandt H.

Appl Health Econ Health Policy. 2008;6(1):67-80.

PMID:
18774871
13.

Cost-effectiveness of the implantable cardioverter-defibrillator: results from the Canadian Implantable Defibrillator Study (CIDS).

O'Brien BJ, Connolly SJ, Goeree R, Blackhouse G, Willan A, Yee R, Roberts RS, Gent M.

Circulation. 2001 Mar 13;103(10):1416-21.

14.

The cost-effectiveness of automatic implantable cardiac defibrillators: results from MADIT. Multicenter Automatic Defibrillator Implantation Trial.

Mushlin AI, Hall WJ, Zwanziger J, Gajary E, Andrews M, Marron R, Zou KH, Moss AJ.

Circulation. 1998 Jun 2;97(21):2129-35.

15.

Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation.

Colquitt JL, Mendes D, Clegg AJ, Harris P, Cooper K, Picot J, Bryant J.

Health Technol Assess. 2014 Aug;18(56):1-560. doi: 10.3310/hta18560. Review.

16.

Cost effectiveness of the implantable cardioverter defibrillator: a preliminary analysis.

O'Brien BJ, Buxton MJ, Rushby JA.

Br Heart J. 1992 Aug;68(2):241-5.

17.
18.

Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population.

Chan PS, Stein K, Chow T, Fendrick M, Bigger JT, Vijan S.

J Am Coll Cardiol. 2006 Jul 4;48(1):112-21. Epub 2006 Jun 9.

19.

The cost effectiveness of implantable cardioverter-defibrillators: results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.

Zwanziger J, Hall WJ, Dick AW, Zhao H, Mushlin AI, Hahn RM, Wang H, Andrews ML, Mooney C, Wang H, Moss AJ.

J Am Coll Cardiol. 2006 Jun 6;47(11):2310-8. Epub 2006 May 4.

20.

Lifetime cost-effectiveness of prophylactic implantation of a cardioverter defibrillator in patients with reduced left ventricular systolic function: results of Markov modelling in a European population.

Cowie MR, Marshall D, Drummond M, Ferko N, Maschio M, Ekman M, de Roy L, Heidbuchel H, Verboven Y, Braunschweig F, Linde C, Boriani G.

Europace. 2009 Jun;11(6):716-26. doi: 10.1093/europace/eup068. Epub 2009 Apr 9.

PMID:
19359333

Supplemental Content

Support Center